Management Approaches for Keratoconus: Insights from a National Survey of Corneal Specialists in Saudi Arabia - Top-Institutions - MDSpire

Management Approaches for Keratoconus: Insights from a National Survey of Corneal Specialists in Saudi Arabia

  • By

  • Saud AlJohani

  • Ahmed Y. Al Othman

  • Abdulmajeed Al Khathami

  • Abdulaziz Alshehri

  • November 28, 2025

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Corneal Diseases
    • Keratoconus Management

  • #2

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Corneal Surgery
    • Keratoconus Research

  • #3

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Corneal and External Disease

  • #4

    King Khaled Eye Specialist Hospital
    King Khaled Eye Specialist Hospital

    Riyadh, Saudi Arabia

    Key Differentiators

    • Ophthalmology
    • Corneal Diseases
    • Keratoconus Management

  • #5

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, UK

    Key Differentiators

    • Ophthalmology
    • Corneal Disease
    • Keratoconus Research

Original Source(s)

Management Approaches for Keratoconus: Insights from a National Survey of Corneal Specialists in Saudi Arabia

  • by Saud AlJohani, Ahmed Y. Al Othman, Abdulmajeed Al Khathami, Abdulaziz Alshehri

  • November 28, 2025

Related Content

Texas First for Epioxa Therapy

The first US rollout of FDA-approved epi-on cross-linking aims to improve comfort and recovery for keratoconus patients

  • May 6, 2026

  • 2 min
CXL Outcomes Consistent Across Populations

Ethnicity and age show limited impact on cross-linking outcomes for keratoconus

  • April 16, 2026

  • 3 min
A Chat with Bernie Iliakis of CorneaGen

Bernie Iliakis, president and CEO of CorneaGen, discusses the growing momentum of CTAK to treat keratoconus, how the company is meeting the growing demand for DMEK and DSAEK tissue processing, and more.

  • November 1, 2025

  • 4 min